LMNL Annual CFI
$2.94 M
-$133.21 M-97.84%
31 December 2022
Summary:
As of February 5, 2025, LMNL annual cash flow from investing activities is $2.94 million, with the most recent change of -$133.21 million (-97.84%) on December 31, 2022. During the last 3 years, it has fallen by -$24.26 million (-89.21%).LMNL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Quarterly CFI
$250.50 K
-$2300.00-0.91%
30 June 2023
Summary:
As of February 5, 2025, LMNL quarterly cash flow from investing activities is $250.50 thousand, with the most recent change of -$2300.00 (-0.91%) on June 30, 2023. Over the past year, it has increased by +$198.50 thousand (+381.73%).LMNL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL TTM CFI
$3.34 M
+$198.50 K+6.32%
30 June 2023
Summary:
As of February 5, 2025, LMNL TTM cash flow from investing activities is $3.34 million, with the most recent change of +$198.50 thousand (+6.32%) on June 30, 2023. Over the past year, it has dropped by -$115.76 million (-97.20%).LMNL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -97.8% | +381.7% | -97.2% |
3 y3 years | -89.2% | +224.6% | -88.7% |
5 y5 years | +240.0% | +115.8% | -87.7% |
LMNL Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -97.8% | -99.8% | -97.6% |
Liminal BioSciences Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2023 | - | $250.50 K(-0.9%) | $3.34 M(+6.3%) |
Mar 2023 | - | $252.80 K(-90.5%) | $3.14 M(+7.0%) |
Dec 2022 | $2.94 M(-97.8%) | $2.67 M(+1452.1%) | $2.94 M(-49.1%) |
Sept 2022 | - | $171.70 K(+230.2%) | $5.77 M(-95.2%) |
June 2022 | - | $52.00 K(+11.6%) | $119.10 M(-12.7%) |
Mar 2022 | - | $46.60 K(-99.2%) | $136.37 M(+0.2%) |
Dec 2021 | $136.15 M(+7813.7%) | $5.50 M(-95.2%) | $136.15 M(+2.3%) |
Sept 2021 | - | $113.50 M(+555.1%) | $133.11 M(+600.2%) |
June 2021 | - | $17.33 M(-9731.2%) | $19.01 M(+1182.5%) |
Mar 2021 | - | -$179.90 K(-107.3%) | $1.48 M(-13.8%) |
Dec 2020 | $1.72 M(-93.7%) | $2.47 M(-508.6%) | $1.72 M(-94.1%) |
Sept 2020 | - | -$603.80 K(+200.4%) | $29.22 M(-1.2%) |
June 2020 | - | -$201.00 K(-445.4%) | $29.58 M(+5.0%) |
Mar 2020 | - | $58.20 K(-99.8%) | $28.18 M(+3.6%) |
Dec 2019 | $27.20 M(-701.6%) | $29.96 M(<-9900.0%) | $27.20 M(-841.1%) |
Sept 2019 | - | -$242.60 K(-84.9%) | -$3.67 M(-21.3%) |
June 2019 | - | -$1.60 M(+73.7%) | -$4.67 M(+0.4%) |
Mar 2019 | - | -$922.50 K(+2.2%) | -$4.65 M(+2.8%) |
Dec 2018 | -$4.52 M(-623.6%) | -$902.30 K(-27.1%) | -$4.52 M(-22.0%) |
Sept 2018 | - | -$1.24 M(-21.8%) | -$5.80 M(+8.2%) |
June 2018 | - | -$1.58 M(+98.9%) | -$5.36 M(-9.5%) |
Mar 2018 | - | -$796.50 K(-63.4%) | -$5.92 M(-786.2%) |
Dec 2017 | $863.40 K(-88.5%) | -$2.18 M(+172.3%) | $863.40 K(-95.7%) |
Sept 2017 | - | -$800.40 K(-62.7%) | $20.28 M(+8.1%) |
June 2017 | - | -$2.15 M(-135.9%) | $18.77 M(+7.8%) |
Mar 2017 | - | $5.99 M(-65.2%) | $17.41 M(+132.9%) |
Dec 2016 | $7.48 M(-228.4%) | $17.24 M(-845.2%) | $7.48 M(-168.3%) |
Sept 2016 | - | -$2.31 M(-34.0%) | -$10.94 M(+5.2%) |
June 2016 | - | -$3.51 M(-11.0%) | -$10.40 M(+18.3%) |
Mar 2016 | - | -$3.94 M(+234.3%) | -$8.79 M(+51.0%) |
Dec 2015 | -$5.82 M(-26.6%) | -$1.18 M(-33.4%) | -$5.82 M(-9.2%) |
Sept 2015 | - | -$1.77 M(-6.7%) | -$6.41 M(-8.8%) |
June 2015 | - | -$1.90 M(+94.8%) | -$7.03 M(+8.3%) |
Mar 2015 | - | -$974.00 K(-45.0%) | -$6.49 M(-18.1%) |
Dec 2014 | -$7.92 M(+7.1%) | -$1.77 M(-25.9%) | -$7.92 M(-22.8%) |
Sept 2014 | - | -$2.39 M(+75.9%) | -$10.26 M(+9.0%) |
June 2014 | - | -$1.36 M(-43.6%) | -$9.41 M(-1.8%) |
Mar 2014 | - | -$2.41 M(-41.4%) | -$9.58 M(+29.5%) |
Dec 2013 | -$7.40 M(+928.7%) | -$4.11 M(+166.8%) | -$7.40 M(+93.3%) |
Sept 2013 | - | -$1.54 M(+0.9%) | -$3.83 M(+66.3%) |
June 2013 | - | -$1.53 M(+580.5%) | -$2.30 M(+164.6%) |
Mar 2013 | - | -$224.30 K(-58.3%) | -$869.70 K(+20.9%) |
Dec 2012 | -$719.20 K(-30.7%) | -$537.50 K(+3911.2%) | -$719.30 K(-32.7%) |
Sept 2012 | - | -$13.40 K(-85.8%) | -$1.07 M(-6.3%) |
June 2012 | - | -$94.50 K(+27.9%) | -$1.14 M(+6.9%) |
Mar 2012 | - | -$73.90 K(-91.7%) | -$1.07 M(+2.8%) |
Dec 2011 | -$1.04 M(+84.2%) | -$887.50 K(+944.1%) | -$1.04 M(-4317.9%) |
Sept 2011 | - | -$85.00 K(+314.6%) | $24.60 K(-105.0%) |
June 2011 | - | -$20.50 K(-54.0%) | -$494.30 K(-16.9%) |
Mar 2011 | - | -$44.60 K(-125.5%) | -$594.50 K(+5.5%) |
Dec 2010 | -$563.30 K | $174.70 K(-128.9%) | -$563.40 K(-27.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2010 | - | -$603.90 K(+400.3%) | -$781.10 K(+204.3%) |
June 2010 | - | -$120.70 K(+794.1%) | -$256.70 K(+59.3%) |
Mar 2010 | - | -$13.50 K(-68.6%) | -$161.10 K(-19.7%) |
Dec 2009 | -$200.70 K(-41.3%) | -$43.00 K(-45.9%) | -$200.70 K(-16.8%) |
Sept 2009 | - | -$79.50 K(+216.7%) | -$241.20 K(-66.9%) |
June 2009 | - | -$25.10 K(-52.7%) | -$728.00 K(-8.4%) |
Mar 2009 | - | -$53.10 K(-36.4%) | -$794.80 K(+132.5%) |
Dec 2008 | -$341.90 K(-71.6%) | -$83.50 K(-85.3%) | -$341.80 K(+31.8%) |
Sept 2008 | - | -$566.30 K(+516.2%) | -$259.40 K(+264.8%) |
June 2008 | - | -$91.90 K(-123.0%) | -$71.10 K(-83.9%) |
Mar 2008 | - | $399.90 K(<-9900.0%) | -$441.20 K(-63.3%) |
Dec 2007 | -$1.20 M(-26.2%) | -$1100.00(-99.7%) | -$1.20 M(-2.4%) |
Sept 2007 | - | -$378.00 K(-18.2%) | -$1.23 M(+9.3%) |
June 2007 | - | -$462.00 K(+27.4%) | -$1.13 M(-37.9%) |
Mar 2007 | - | -$362.70 K(+1058.8%) | -$1.82 M(+11.5%) |
Dec 2006 | -$1.63 M(-18.8%) | -$31.30 K(-88.6%) | -$1.63 M(+0.5%) |
Sept 2006 | - | -$273.50 K(-76.2%) | -$1.62 M(-157.2%) |
June 2006 | - | -$1.15 M(+557.7%) | $2.84 M(-292.0%) |
Mar 2006 | - | -$174.90 K(+641.1%) | -$1.48 M(-26.4%) |
Dec 2005 | -$2.01 M(-31.6%) | -$23.60 K(-100.6%) | -$2.01 M(-152.3%) |
Sept 2005 | - | $4.18 M(-176.6%) | $3.84 M(-151.1%) |
June 2005 | - | -$5.46 M(+675.1%) | -$7.52 M(-181.3%) |
Mar 2005 | - | -$704.80 K(-112.1%) | $9.24 M(-415.2%) |
Dec 2004 | -$2.93 M(-162.9%) | $5.82 M(-181.2%) | -$2.93 M(-67.6%) |
Sept 2004 | - | -$7.17 M(-163.5%) | -$9.05 M(+541.2%) |
June 2004 | - | $11.30 M(-187.7%) | -$1.41 M(-89.3%) |
Mar 2004 | - | -$12.88 M(+4218.4%) | -$13.20 M(-382.9%) |
Dec 2003 | $4.67 M(-160.6%) | -$298.30 K(-163.4%) | $4.67 M(-1003.9%) |
Sept 2003 | - | $470.40 K(-196.2%) | -$516.20 K(-59.6%) |
June 2003 | - | -$489.10 K(-109.8%) | -$1.28 M(-29.6%) |
Mar 2003 | - | $4.98 M(-190.9%) | -$1.82 M(-76.4%) |
Dec 2002 | -$7.70 M(+1233.4%) | -$5.48 M(+1783.3%) | -$7.70 M(+138.7%) |
Sept 2002 | - | -$291.00 K(-71.7%) | -$3.22 M(+2.4%) |
June 2002 | - | -$1.03 M(+14.5%) | -$3.15 M(+18.4%) |
Mar 2002 | - | -$896.60 K(-11.2%) | -$2.66 M(+360.9%) |
Dec 2001 | -$577.10 K(-85.0%) | -$1.01 M(+367.2%) | -$577.20 K(-72.9%) |
Sept 2001 | - | -$216.10 K(-59.8%) | -$2.13 M(-3.0%) |
June 2001 | - | -$538.00 K(-145.3%) | -$2.20 M(-8.3%) |
Mar 2001 | - | $1.19 M(-146.3%) | -$2.40 M(-37.9%) |
Dec 2000 | -$3.86 M(+112.4%) | -$2.56 M(+805.5%) | -$3.86 M(+67.3%) |
Sept 2000 | - | -$283.10 K(-61.6%) | -$2.31 M(+14.4%) |
June 2000 | - | -$738.00 K(+168.2%) | -$2.02 M(+6.4%) |
Mar 2000 | - | -$275.20 K(-72.8%) | -$1.89 M(+4.2%) |
Dec 1999 | -$1.82 M(+144.7%) | -$1.01 M(<-9900.0%) | -$1.82 M(+125.2%) |
Sept 1999 | - | $7600.00(-101.2%) | -$807.20 K(-0.9%) |
June 1999 | - | -$616.40 K(+210.7%) | -$814.80 K(+40.6%) |
Mar 1999 | - | -$198.40 K(-47.9%) | -$579.50 K(-82.2%) |
Dec 1998 | -$742.60 K(-40.2%) | - | - |
June 1998 | - | -$381.10 K(-67.3%) | -$3.25 M(+13.3%) |
Mar 1998 | - | -$1.16 M(-31.6%) | -$2.87 M(+68.4%) |
Dec 1997 | - | -$1.70 M | -$1.70 M |
Sept 1997 | -$1.24 M | - | - |
FAQ
- What is Liminal BioSciences annual cash flow from investing activities?
- What is the all time high annual CFI for Liminal BioSciences?
- What is Liminal BioSciences annual CFI year-on-year change?
- What is Liminal BioSciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Liminal BioSciences?
- What is Liminal BioSciences quarterly CFI year-on-year change?
- What is Liminal BioSciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Liminal BioSciences?
- What is Liminal BioSciences TTM CFI year-on-year change?
What is Liminal BioSciences annual cash flow from investing activities?
The current annual CFI of LMNL is $2.94 M
What is the all time high annual CFI for Liminal BioSciences?
Liminal BioSciences all-time high annual cash flow from investing activities is $136.15 M
What is Liminal BioSciences annual CFI year-on-year change?
Over the past year, LMNL annual cash flow from investing activities has changed by -$133.21 M (-97.84%)
What is Liminal BioSciences quarterly cash flow from investing activities?
The current quarterly CFI of LMNL is $250.50 K
What is the all time high quarterly CFI for Liminal BioSciences?
Liminal BioSciences all-time high quarterly cash flow from investing activities is $113.50 M
What is Liminal BioSciences quarterly CFI year-on-year change?
Over the past year, LMNL quarterly cash flow from investing activities has changed by +$198.50 K (+381.73%)
What is Liminal BioSciences TTM cash flow from investing activities?
The current TTM CFI of LMNL is $3.34 M
What is the all time high TTM CFI for Liminal BioSciences?
Liminal BioSciences all-time high TTM cash flow from investing activities is $136.37 M
What is Liminal BioSciences TTM CFI year-on-year change?
Over the past year, LMNL TTM cash flow from investing activities has changed by -$115.76 M (-97.20%)